In recent years, JNK has been increasingly recognized as an attractive molecular target for cancer treatment due to its involvement in the regulation of cellular processes associated with carcinogenesis, including proliferation, differentiation and survival of tumor cells. This evidence concerns the gene MAPK8 and neoplasm.